comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 00:48:41 - browse：89868

Axovant Sciences(AXON) is the main event in biotech’s September cavalcade of clinical trial readouts, but while we wait, it’s a good idea to prep for important — and stock-moving — data releases from Zogenix(ZGNX) and Amicus Therapeutics(FOLD).

Zogenix’s lead drug, called ZX008, is a low-dose liquid formulation of the old serotonin booster fenfluramine. The company is developing ZX008 to treat children with Dravet syndrome, a rare and severe type of epilepsy.

You might remember fenfluramine as part of the “fen-phen” obesity regimen that was pulled from the market in 1997 because fenfluramine (at a higher dose) caused severe damage to people’s heart valves.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： ALS advocates say criticism of new drugs misses bigger picture

WSS

The (many) problems with a new study criticizing cancer screening

A new House health package & hospitals’ new site

Why the Crimean Bridge is key to Russia's war in Ukraine

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Illumina names Agilent executive as new CEO

Humana sues Biden admin over Medicare Advantage audit rule

explore

comprehensive

Wikipedia

In age of alternative facts, a scholarly course on calling out crap

Illumina names Agilent executive as new CEO

Duchenne breakthrough therapy leaves behind pioneering families

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Drug repurposing or repositioning? The language matters

Ethical issues complicate the benefits of medical crowdfunding

In age of alternative facts, a scholarly course on calling out crap

How to protect patients from sexual assault

BioMarin wins approval for gene therapy to treat hemophilia A

Medicaid rebukes states for mistakenly disenrolling children

hotspot

Norman Reedus' Daryl Dixon

Advances in CAR

The kidney, in all its complexity, is captured in a new atlas

The kidney, in all its complexity, is captured in a new atlas

Medicaid rebukes states for mistakenly disenrolling children

Humana sues Biden admin over Medicare Advantage audit rule

entertainment

focus

knowledge

entertainment